D M Grote

596 total citations
8 papers, 487 citations indexed

About

D M Grote is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology. According to data from OpenAlex, D M Grote has authored 8 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 5 papers in Immunology and 4 papers in Oncology. Recurrent topics in D M Grote's work include Lymphoma Diagnosis and Treatment (5 papers), Immune Cell Function and Interaction (4 papers) and Multiple Myeloma Research and Treatments (2 papers). D M Grote is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Immune Cell Function and Interaction (4 papers) and Multiple Myeloma Research and Treatments (2 papers). D M Grote collaborates with scholars based in United States and China. D M Grote's co-authors include Anne J. Novak, Stephen M. Ansell, Tammy Price-Troska, Lucy S. Hodge, David Yates, Steve Ziesmer, Steven C. Ziesmer, A Fielding, S. Vincent Rajkumar and Diane F. Jelinek and has published in prestigious journals such as Leukemia and Blood Cancer Journal.

In The Last Decade

D M Grote

8 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D M Grote United States 8 273 263 153 147 52 8 487
Maike Sauer Germany 8 317 1.2× 214 0.8× 97 0.6× 125 0.9× 38 0.7× 11 464
Matthew J. Ahearne United Kingdom 13 194 0.7× 264 1.0× 257 1.7× 85 0.6× 117 2.3× 26 499
Sara Tedoldi United Kingdom 8 177 0.6× 169 0.6× 204 1.3× 70 0.5× 70 1.3× 9 429
Weihong Chen China 5 152 0.6× 186 0.7× 209 1.4× 117 0.8× 136 2.6× 8 396
Alexandra Schrader Germany 9 150 0.5× 189 0.7× 203 1.3× 103 0.7× 142 2.7× 20 402
Janice P. Dutcher United States 9 140 0.5× 356 1.4× 98 0.6× 144 1.0× 45 0.9× 12 489
Athalia R. Pyzer United States 9 200 0.7× 183 0.7× 56 0.4× 156 1.1× 18 0.3× 23 398
Bertrand Montpellier France 6 163 0.6× 143 0.5× 144 0.9× 209 1.4× 103 2.0× 9 506
Junichiro Yuda Japan 10 289 1.1× 268 1.0× 58 0.4× 198 1.3× 63 1.2× 43 566
Ellen J. van Gastel-Mol Netherlands 9 266 1.0× 139 0.5× 171 1.1× 57 0.4× 95 1.8× 12 442

Countries citing papers authored by D M Grote

Since Specialization
Citations

This map shows the geographic impact of D M Grote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D M Grote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D M Grote more than expected).

Fields of papers citing papers by D M Grote

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D M Grote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D M Grote. The network helps show where D M Grote may publish in the future.

Co-authorship network of co-authors of D M Grote

This figure shows the co-authorship network connecting the top 25 collaborators of D M Grote. A scholar is included among the top collaborators of D M Grote based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D M Grote. D M Grote is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Grote, D M, et al.. (2015). PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival. Blood Cancer Journal. 5(2). e281–e281. 119 indexed citations
2.
Lin, Yi, D M Grote, Steven C. Ziesmer, et al.. (2015). IL-10 induces the development of immunosuppressive CD14+HLA-DRlow/− monocytes in B-cell non-Hodgkin lymphoma. Blood Cancer Journal. 5(7). e328–e328. 79 indexed citations
3.
Grote, D M, Steve Ziesmer, Tammy Price-Troska, et al.. (2014). TGF-β upregulates CD70 expression and induces exhaustion of effector memory T cells in B-cell non-Hodgkin’s lymphoma. Leukemia. 28(9). 1872–1884. 107 indexed citations
4.
Ramakrishnan, Vijay, Stephen M. Ansell, Janine Haug, et al.. (2011). MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma. Leukemia. 26(2). 340–348. 60 indexed citations
5.
Ansell, Stephen M., Hui Tang, Paul J. Kurtin, et al.. (2011). Denileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphoma. Leukemia. 26(5). 1046–1052. 12 indexed citations
6.
Hodge, Lucy S., Sherine F. Elsawa, D M Grote, et al.. (2011). MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts. Blood Cancer Journal. 1(6). e24–e24. 19 indexed citations
7.
Novak, Anne J., D M Grote, Steven C. Ziesmer, et al.. (2008). A role for IFN-λ1 in multiple myeloma B cell growth. Leukemia. 22(12). 2240–2246. 18 indexed citations
8.
Ansell, Stephen M., D M Grote, Diane F. Jelinek, et al.. (2004). Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma. Leukemia. 18(3). 616–623. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026